Insights on Melatonin as an Active Pharmacological Molecule in Cancer Prevention: What's New?


Journal

Current medicinal chemistry
ISSN: 1875-533X
Titre abrégé: Curr Med Chem
Pays: United Arab Emirates
ID NLM: 9440157

Informations de publication

Date de publication:
2019
Historique:
received: 19 01 2018
revised: 10 04 2018
accepted: 18 04 2018
pubmed: 2 5 2018
medline: 27 12 2019
entrez: 2 5 2018
Statut: ppublish

Résumé

Along with playing an important role in circadian rhythm, melatonin is thought to play a significant role in preventing cells from damage, as well as in the inhibition of growth and in triggering apoptosis in malignant cells. Its relationship with circadian rhythms, energetic homeostasis, diet, and metabolism, is fundamental to achieve a better comprehension of how melatonin has been considered a chemopreventive molecule, though very few papers dealing with this issue. In this article, we tried to review the most recent evidence regarding the protective as well as the antitumoral mechanisms of melatonin, as related to diet and metabolic balance. From different studies, it was evident that an intracellular antioxidant defense mechanism is activated by upregulating an antioxidant gene battery in the presence of high-dose melatonin in malignant cells. Like other broad-spectrum antioxidant molecules, melatonin plays a vital role in killing tumor cells, preventing metastasis, and simultaneously keeping normal cells protected from oxidative stress and other types of tissue damage.

Identifiants

pubmed: 29714136
pii: CMC-EPUB-90107
doi: 10.2174/0929867325666180501094850
doi:

Substances chimiques

Melatonin JL5DK93RCL

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

6304-6320

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Geir Bjørklund (G)

Council for Nutritional and Environmental Medicine, Mo i Rana, Norway.

Samiul Alam Rajib (SA)

Department of Pharmacy, BRAC University, Dhaka, Bangladesh.

Nadia Saffoon (N)

Department of Pharmacy and Forensic Science, Faculty of Life Science and Medicine, King's College London, London, United Kingdom.

Joeri J Pen (JJ)

Diabetes Clinic, Department of Internal Medicine, UZ Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Department of Nutrition, UZ Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium.

Salvatore Chirumbolo (S)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH